Tricor Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Fenofibrate Sponsors:   Tanta University;   Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University;   Fedaa Abd El-monem Kamal El-deen Kotkata Faculty of Pharmacy, Tanta University;   Manal Ali Mahrous Hamouda Faculty of Pharmacy, Menufia University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials